3/30/2022 | CV | Market Commentary: Convertibles quiet; Neogenomics rebounds; Shift4, Pinduoduo, Western Digital active
|
10/1/2021 | CV | Market Commentary: Five9 in focus after Zoom merger failure; Guardant Health down, NeoGenomics up on buyout
|
1/8/2021 | CV | Market Commentary: Summit Hotel convertibles soar on debut; Sarepta tanks outright, jumps dollar-neutral
|
1/7/2021 | CV | Market Commentary: Summit Hotel convertible offering eyed; NeoGenomics soars on debut; Uber notes active
|
1/7/2021 | CV | Market Commentary: Morning Commentary: Summit Hotel convertible offering eyed; NeoGenomics soars on debut
|
1/7/2021 | CV | New Issue: NeoGenomics prices upsized $300 million seven-year convertibles at 0.25%, up 35%
|
1/6/2021 | CV | Market Commentary: Summit Hotel convertibles on deck; NeoGenomics eyed; NextEra soars; Tilray in focus
|
1/6/2021 | CV | Market Commentary: Morning Commentary: NeoGenomics convertible offering eyed; Tilray notes in focus early
|
1/5/2021 | CV | Market Commentary: NeoGenomics opens convertible primary market; iQIYI, Pinduoduo gain; NextEra tops par
|
1/5/2021 | CV | NeoGenomics talks $250 million seven-year convertible notes to yield 0.25%-0.75%, up 30%-35%
|
4/30/2020 | CV | Market Commentary: Callaway Golf, NeoGenomics convertibles expand on debut; Southwest Airlines in focus
|
4/30/2020 | CV | Market Commentary: Morning Commentary: Callaway Golf, NeoGenomics convertibles expand on debut
|
4/30/2020 | CV | New Issue: NeoGenomics prices upsized $175 million five-year convertibles at 1.25%, up 27.5%
|
4/29/2020 | CV | NeoGenomics talks $150 million five-year convertible notes to yield 1.25%-1.75%, up 25%-30%
|
4/29/2020 | CV | Market Commentary: NeoGenomics on tap; Callaway tightens talk; Southwest up; CNX, Rapid7 expand on debut
|
6/25/2018 | BK | NeoGenomics Laboratories obtains new $30 million term loan facility
|
3/23/2018 | BK | NeoGenomics makes covenant changes to $150 million credit agreement
|
12/28/2016 | BK | NeoGenomics adds details to revolver, term loan totaling $150 million
|
12/22/2016 | BK | NeoGenomics closes on revolver, term loan totaling $150 million
|
12/31/2015 | BK | NeoGenomics closes on revolver, term loan totaling $80 million
|
8/22/2014 | PP | NeoGenomics greenshoe exercised in $37.03 million public sale of stock
|
8/15/2014 | PP | NeoGenomics prices $32.2 million public offering of stock at $4.60
|
8/14/2014 | PP | NeoGenomics announces plans to price public offering of common stock
|
2/28/2013 | PP | NeoGenomics prices $8.55 million public sale of common stock at $3.00
|
2/21/2013 | PP | NeoGenomics reports plans to price public sale of 2.7 million shares
|
1/13/2011 | PP | NeoGenomics raises $3 million from common stock private placement
|
7/30/2009 | PP | New Issue: NeoGenomics completes $4.77 million private placement of common stock
|
7/30/2009 | PP | Market Commentary: EcoSystem to take in $76.62 million; Inovio plans sale; Legend looks to improve balance sheet
|
6/7/2007 | PP | Market Commentary: Osteologix raises $5.05 million from unit offering; NeoGenomics settles stock sale
|
6/7/2007 | PP | New Issue: NeoGenomics raises $4 million from stock offering
|
7/18/2006 | BT | NeoGenomics second-quarter revenues up 41.3% to $1.767 million
|
6/8/2005 | PP | New Issue: NeoGenomics gets $5 million equity line
|
6/8/2005 | PP | Market Commentary: Whittier Energy arranges $50 million private placement; energy companies return to PIPE market
|